MOLECULAR STUDY OF CALR GENE: MYELOPROLIFERATIVE NEOPLASMS (MPN) WITH NEGATIVE PHILADELPHIA AND JAK2/V617F

被引:0
作者
Culurgioni, F. [1 ]
Musiu, C. [1 ]
Uda, S. [1 ]
Benziane, A. [1 ]
Pettinau, M. [1 ]
Usala, E. [1 ]
Cabras, M. G. [1 ]
机构
[1] Ctr Trapianti Midollo Osseo PO A Businco Ao Brotz, Unita Operat Ematol, Cagliari, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PU039
引用
收藏
页码:167 / 168
页数:2
相关论文
共 50 条
[21]   The JAK2 V617F Mutation in Pediatric Myeloproliferative Neoplasms: How and When? [J].
Langabeer, Stephen E. ;
Smith, Owen P. ;
McMahon, Corrina .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2014, 31 (02) :138-139
[22]   New advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms [J].
Zhang, Yongchao ;
Zhao, Yue ;
Liu, YuSi ;
Zhang, Minyu ;
Zhang, Jihong .
CANCER, 2024, 130 (24) :4229-4240
[23]   Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms [J].
Zhang, Shu-Peng ;
Li, Hui ;
Lai, Ren-Sheng .
ONCOLOGY LETTERS, 2015, 9 (02) :735-738
[24]   Analysis of JAK2 V617F mutation in Tunisian patients with myeloproliferative neoplasms [J].
Chadi, Soumaya ;
Dhaouadi, Tarak ;
Sfar, Imen ;
Baccouche, Hela ;
Nabli, Rym ;
Ben Romdhane, Neila ;
Ben Abdallah, Taieb ;
Gorgi, Yousr .
EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
[25]   Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN) [J].
Zulkeflee, Razan Hayati ;
Zulkafli, Zefarina ;
Johan, Muhammad Farid ;
Husin, Azlan ;
Islam, Md Asiful ;
Hassan, Rosline .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (14)
[26]   THROMBOEMBOLIC AND HEMORRHAGIC COMPLICATIONS AND JAK2 V617F MUTATION POSITIVITY IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISEASES [J].
Unubol, M. ;
Yavsoglu, I. ;
Bozkurt, G. ;
Kadikoylu, G. ;
Bolaman, Z. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 :590-590
[27]   JAK2 V617F mutation and the myeloproliferative disorders [J].
Vainchenker, William ;
Casadevall, Nicole .
HEMATOLOGIE, 2006, 12 (01) :3-7
[28]   The JAK2 V617F mutation in the myeloproliferative disorders [J].
Sale, MA ;
Awan, A ;
Lucas, GS ;
Yin, JAL .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 :33-33
[29]   GLS in Philadelphia-negative and JAK2 V617F-driven myeloproliferative neoplasms (MPNs). [J].
Ciboddo, Michele ;
Yan, George ;
Coen, Chad ;
Dowgielewicz, Jonathan ;
Blaylock, Hunter ;
Arellano, Nicole S. ;
Zawieracz, Katarzyna ;
Rosencrance, Alex ;
Casetti, Ilaria C. ;
Borsani, Oscar ;
Catricala, Silvia ;
Vanni, Daniele ;
Saygin, Caner ;
McNerney, Megan ;
Faubert, Brandon ;
Pietra, Daniela ;
Rumi, Elisa ;
Elf, Shannon Elizabeth .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[30]   The V617F JAK2 mutation and the myeloproliferative disorders [J].
Percy, MJ ;
McMullin, MF .
HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) :91-93